tiprankstipranks
Trending News
More News >
Duality Biotherapeutics, Inc. (HK:9606)
:9606
Hong Kong Market
Advertisement

Duality Biotherapeutics, Inc. (9606) Income Statement

Compare
2 Followers

Duality Biotherapeutics, Inc. Income Statement

Last quarter (Q2 2025), Duality Biotherapeutics, Inc.'s total revenue was ¥614.47M, a decrease of 0.00% from previous quarter. In Q2, Duality Biotherapeutics, Inc.'s net income was ¥-1.04B. See Duality Biotherapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22
Total Revenue
¥ 1.94B¥ 1.79B¥ 1.60M
Gross Profit
¥ 784.67M¥ 1.36B¥ 1.60M
Operating Expenses
¥ 973.66M¥ 577.53M¥ 370.18M
Depreciation and Amortization
¥ 7.87M¥ 4.99M¥ 1.79M
EBITDA
¥ -1.01B¥ -197.07M¥ -385.22M
Operating Income
¥ -188.99M¥ 781.36M¥ -368.58M
Other Income/Expenses
¥ -825.55M¥ -983.60M¥ -18.51M
Pretax Income
¥ -1.01B¥ -202.25M¥ -387.09M
Net Income
¥ -1.05B¥ -357.51M¥ -387.09M
Per Share Metrics
Basic EPS
¥ -12.63¥ -4.30¥ -4.65
Diluted EPS
¥ -12.63¥ -4.30¥ -4.65
Weighted Average Shares Outstanding
83.18M 83.18M 83.18M
Weighted Average Shares Outstanding (Diluted)
83.18M 83.18M 83.18M
Currency in CNY

Duality Biotherapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis